24/7 Support Number +91-9137-44-1392

UHAPO: Cancer Community Forum

How does genetics p...
 
Notifications
Clear all

How does genetics play a role in lung cancer ?

2 Posts
2 Users
1 Reactions
296 Views
14f4ebf66f7a7cd7f8fe6bb531e1adc2?s=80&d=mm&r=g
Posts: 87
Topic starter
(@chandra)
Reputable Member
Joined: 1 year ago

I wanted to know about how much or how may genetics play a role in causing cancer or developing lung cancer specifically ?

1 Reply
fef4ae5cfd6ed6a4a64a6e6c00fb4209?s=80&d=mm&r=g
Posts: 65
 yog
Registered
(@uhapoadmin)
Member
Joined: 3 years ago

Genetics plays a significant role in the development of lung cancer. Both inherited genetic factors and acquired genetic mutations can contribute to an individual's susceptibility to developing lung cancer. Here's how genetics impacts lung cancer:

Inherited Genetic Factors:

  1. Family History: Having a family history of lung cancer can increase the risk of developing the disease. If a first-degree relative (parent, sibling, child) has had lung cancer, the risk is higher.
  2. Genetic Mutations: Certain genetic mutations, such as mutations in the BRCA genes, have been linked to an increased risk of lung cancer. These mutations are usually associated with other types of cancer, like breast and ovarian cancer, but can also impact lung cancer risk.
  3. Genetic Syndromes: Some rare genetic syndromes, such as Li-Fraumeni syndrome and hereditary retinoblastoma, can predispose individuals to various types of cancer, including lung cancer.

Acquired Genetic Mutations:

  1. Somatic Mutations: Somatic mutations are genetic changes that occur during a person's lifetime due to exposure to carcinogens (cancer-causing substances) like tobacco smoke, environmental pollutants, and radiation. These mutations can accumulate in lung cells, leading to the development of cancer.
  2. Driver Mutations: Certain genetic mutations are known as "driver mutations" because they play a key role in driving the growth of cancer cells. For example, mutations in genes like EGFR, ALK, ROS1, and BRAF are associated with non-small cell lung cancer (NSCLC) and can guide treatment decisions.
  3. Targeted Therapies: Understanding the genetic profile of a person's tumor can help oncologists select targeted therapies that specifically target the mutated genes driving the cancer's growth.
  4. Immunotherapy: Genetic factors influence how the immune system responds to cancer. Immunotherapy drugs like checkpoint inhibitors work by blocking certain interactions that cancer cells use to evade immune detection.

It's important to note that while genetics play a role in lung cancer risk, they are just one piece of a complex puzzle. Environmental factors, such as tobacco smoke, secondhand smoke, air pollution, and occupational exposures, also significantly contribute to lung cancer development. Additionally, not everyone with genetic mutations will develop lung cancer, and not everyone who develops lung cancer has a family history or specific genetic mutation.

For individuals with a family history of lung cancer or certain genetic syndromes, genetic counseling and testing may be recommended. This can provide valuable information about individual risk factors and guide appropriate screenings and preventive measures

Reply
Share:

© 2024 Uhapo Health Services (P) Ltd.

Get In Touch

Get In Touch

Book An Appointment